Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also received a Bachelor of Arts in journalism and was editor-in-chief of her college newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have 3 young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

Psoriatic Arthritis

Biologic Agents Reduce Psoriatic Arthritis Incidence

Estie Mermelstein, MSN, FNP-BC

October 13, 2021

The effect of psoriasis treatment with biologic agents and incidence of psoriatic arthritis is examined.

Risk of stroke after herpes zoster in patients with autoimmune diseases

Rheumatoid Arthritis Advisor

Increased Herpes Zoster Risk in Patients With RA Treated With Biologic DMARDs

Estie Mermelstein, MSN, FNP-BC

October 7, 2021

Event and incidence rates of herpes zoster in patients with RA treated with biologic, tsDMARDs are compared.

General Rheumatology

Decreased Seroconversion Rates After COVID-19 Vaccination in Patients With Immune-Mediated Inflammatory Diseases

Estie Mermelstein, MSN, FNP-BC

October 1, 2021

Investigators conducted a systemic review to assess the effects of various medications on seroconversion rates following SARS-CoV-2 vaccination in patients with immune mediated inflammatory disease.

General Medicine

Therapeutic-Dose Heparin Improves Survival Outcomes in Patients Hospitalized With COVID-19

Estie Mermelstein, MSN, FNP-BC

September 15, 2021

Investigators conducted a multiplatform trial to compare the effects of therapeutic-dose heparin with standard care thromboprophylaxis for the treatment of patients hospitalized with moderate COVID-19.

General Medicine

Adverse Effects Among Vaccinated Individuals Reported in the COVID Symptom Study App

Estie Mermelstein, MSN, FNP-BC

September 1, 2021

Investigators compared adverse effects of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines reported in the COVID Symptom Study App with those reported during phase 3 trials.

Pediatric Rheumatology

Data Lacking on Biologic and JAK Inhibitor Therapies for Pediatric Rheumatology Patients

Estie Mermelstein, MSN, FNP-BC

July 16, 2021

Randomized, controlled trials in pediatric inflammatory rheumatic diseases (PiRDs) of patients who underwent bDMARDs and JAK inhibitors are reviewed.

General Rheumatology

Low Immune Response to Clostridioides difficile Treatment in Immunosuppressed Patients

Estie Mermelstein, MSN, FNP-BC

July 13, 2021

Investigators assessed the immune response to Clostridioides difficile in immunocompromised patients.

Systemic Lupus Erythematosus

Cytomegalovirus Risk Higher With Immunosuppressive Treatment for Systemic Lupus Erythematosus

Estie Mermelstein, MSN, FNP-BC

June 29, 2021

Investigators assessed the role of cell-mediated immunity in the development of cytomegalovirus infection in patients with systemic lupus erythematosus undergoing treatment with immunosuppressants.

General Rheumatology

Moderna, Pfizer-BioNTech COVID-19 Vaccines Provide Immunity in Pregnant Women

Estie Mermelstein, MSN, FNP-BC

June 28, 2021

Investigators assessed response to vaccination with the Moderna or Pfizer-BioNTech COVID-19 vaccines in pregnant and nonpregnant lactating women.

General Rheumatology

COVID-19 Antibodies Detected in Breast Milk of Vaccinated Mothers

Estie Mermelstein, MSN, FNP-BC

May 14, 2021

Investigators vaccinated exclusively or partially breastfeeding women and examined their breast milk samples to determine levels of antibodies against SARS-CoV-2.

Next post in General Rheumatology